On Friday, AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials ...
Please provide your email address to receive an email when new articles are posted on . Two doses of PPSV23 5 years apart are recommended. Stratifying T-cell deficiencies can help ensure safe ...
Earlier identification of children at risk of asthma could promote active disease monitoring and treatment interventions, the authors wrote. An international team of researchers found that a ...
ANAHEIM, Calif. (Nov. 9, 2023) – Biologics for the treatment of asthma were first introduced about 20 years ago. Since then, more and more people with asthma have found them to be an effective ...
"The strength of the associations of the biomarkers with higher risk of thunderstorm asthma and hospitalization in those with rhinitis was a surprise. In particular the threshold of allergen specific ...
One cause of apparently resistant asthma is ‘wrong diagnosis’ – what are the differentials we should be aware of, and how can we distinguish them from true asthma? Resistant asthma is asthma that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results